{"name":"Kiadis Pharma","slug":"kiadis-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQdjFfTDJYS2RMSUZDVTBnU1hSNFg1M0VmRm1sV1ZZLVpZM1hrMkpISXMyN3FmVzAzOG1LalNndW9ySEg5SUdpNkh6di1idFhIWTBhWklILTZBT2JFeFZGLThYTEpqTDE4LW1WdlFOVEdZM2Fkd2xJVFBoaXVEUmJQcDJOaW1Cei1QUzh1Wlp4Uk56STNIeUFv?oc=5","date":"2024-03-03","type":"deal","source":"BioProcess International","summary":"Natural killer deal: Sanofi buying Kiadis for $358m - BioProcess International","headline":"Natural killer deal: Sanofi buying Kiadis for $358m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNZkxPZ3VXTS1td1JuUXIwbGNKT1h3WmpLeTlHa0hCUG55bkp2cGIxVlNUS204M0JvRTIwVFpXMjdCbE1YYWRGSklURThDdGdld2JmZFY5OGVIQm9Hb3hhcEJZRnRVVzFLSWlQZTJFY2tHdHJkZVdsOHZ5T3hzZEZRWHFyYm5ETDFQNGNiZ3VDMW1UVFVLc25LTl9OV1JHMnM?oc=5","date":"2020-11-02","type":"deal","source":"Fierce Biotech","summary":"Sanofi inks $358M Kiadis takeover to acquire NK-cell platform - Fierce Biotech","headline":"Sanofi inks $358M Kiadis takeover to acquire NK-cell platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQaVQzaVNhSWdQZC1MZDNZMENydUNxTjhvbl9Sckpmcmp4VHhVLURTMEtaLTBSR2ZpTUhZeDhVQ2NFeUFUWExlRHBIM3YtRVJTa2ExaUV5OVhNb1VmUExaZ3NDRFl2STJ3eGh4YXZKQjBzWTRYRENsT2ttLU9VRE44MElJd09ZaW9qOV9aS2dn?oc=5","date":"2020-11-02","type":"deal","source":"BioPharma Dive","summary":"Revamp pays off for Kiadis with $358M Sanofi buyout - BioPharma Dive","headline":"Revamp pays off for Kiadis with $358M Sanofi buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNZ2Qzc3hGSU5sSmc5LXRlYWVXRUprRmNFQzFXUXdqcVYzNlNFZmxkQ244ZkdiNWVFS19aVTlldVl0ZGtCaHRHYWZqZUdsRnotektrNFMwcWs3WmIyVkdKelJUc0JfV2d6QjljYlZTX0F5bDdDcmpNalNvNzJwTHU1UjY3dUExdw?oc=5","date":"2020-10-28","type":"pipeline","source":"labiotech.eu","summary":"Do Natural Killer Cells Hold the Key to Treating Blood Cancers? - labiotech.eu","headline":"Do Natural Killer Cells Hold the Key to Treating Blood Cancers?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNc1ZtQUtwVnV1YnlwU25pVUNwdC1UYklKb01jWnlfTmJYalI5NzVlLUpUT1FRb0w2cWdIbU1hN0ZFWEdfdFluSEFMQUZBd1VQUlpjMy1neDVVWlVUZmVkNnlDTEo1M1dpSFZoNWpfdTdLbVZKR1ZiOG5fYVFtZ3lEUHoxVkd0WDZP?oc=5","date":"2020-07-29","type":"deal","source":"Pharmaceutical Technology","summary":"Sanofi licenses Kiadis’s modified NK cell therapy for multiple myeloma - Pharmaceutical Technology","headline":"Sanofi licenses Kiadis’s modified NK cell therapy for multiple myeloma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOcGt5TjNhQXR6d1ZSVmRQbXhFSzRqM3A2eGM0REJHTndpNUl1dGVWSTZDMks2Qzk1b0pwa0JqUGRtZzR6UTFfcW1hLXNlaTZhekpsZzY4bUdBYWpRaHpZY3liUTBtVjZYMW1EZ2NERW9rYXIwNGtwQmxWVFdPSGdyU2M4UnI0R1ZuNFZKMm53SlZBZ0hLMVJfMmhzN2pCYVE?oc=5","date":"2020-07-08","type":"deal","source":"BioSpace","summary":"Sanofi Licenses Natural Killer Cancer Program from Kiadis in $987 Million Deal - BioSpace","headline":"Sanofi Licenses Natural Killer Cancer Program from Kiadis in $987 Million Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNalJjNmhORGdSVkgxUGxTcGlBM3RuWGcyOFBKdVJtc0c3aVdYT1FFMWVXdHpJVXhjcDBtSjdxMUVjQV8wREg5VlRDZEtGSFNxNUIwRTI5cDdINjREaTN2cXdxSzNCVXEyU3dyQjE1NXJkcmNnSGlvdTJQY1p6eW82QUhsQm9kODlWNTlwNg?oc=5","date":"2019-11-14","type":"pipeline","source":"pharmaphorum","summary":"Kiadis sheds half its staff as lead cell therapy bombs - pharmaphorum","headline":"Kiadis sheds half its staff as lead cell therapy bombs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPdUlzemdrVFl6bm83OE90YkVRVG80a0I2anphU3lRRUhWRHJ3N2NZMUJMWE1rdHRaY21aYUlTYXltUzZkLVdKbHlIYUpzVFdtUW9qZ1JGMXRIWHBBMElJaU1UMmdoTDNqYWF5ek9WdnJtX0dmbW9tTHFaTFppT01RZENGRGcxVUllVHptMVJxdzhVcS1aa3MxTGxONWNITVE?oc=5","date":"2019-11-13","type":"trial","source":"Fierce Biotech","summary":"Kiadis dumps phase 3 drug, halves head count in pivot to NK cells - Fierce Biotech","headline":"Kiadis dumps phase 3 drug, halves head count in pivot to NK cells","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPNS1odFFOUnpLek9uc0pmVk1VRVhiZ3VfUkhNal94SHJUOTVaSkxjbksyeWhUYWNPTkN2OWVUTnBpaWNiNTdHc0ZaYXlNNnRPelpmemdOYjFKYWhJRWk2d3VvaW1hMXB0U0YyUG8wa2g2ZnBjMmFZcWctaW9IU055eDdqVWt5d29jTjVPN2pVVkt4Y1Q3MF85NWJGMGxkTnNORmNGOXhWODdBN3AzVzloZw?oc=5","date":"2019-11-12","type":"pipeline","source":"Citeline News & Insights","summary":"Jumping Before They Were Pushed – Kiadis And Aradigm Withdraw EU Filings - Citeline News & Insights","headline":"Jumping Before They Were Pushed – Kiadis And Aradigm Withdraw EU Filings - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1NazFtZG0xVkVNMTRtYXVDWnZzbldjSjJmTTVMdmRGVklQamZVRkd5RnVVZEY5OFVhUGVOVG9DRC1JWGhpc0E3ejVsaDZkTEx2d01KVGRGR0V0TE42WFhoX1pCNGpUYVJMeU53OUpKNHRjNzFDcWc?oc=5","date":"2019-07-26","type":"deal","source":"Florida Trend","summary":"$70 million CytoSen deal - Florida Trend","headline":"$70 million CytoSen deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQZlNteExQTmI4Vzh1UFcxZjVWV2dsQkhOOWpPbkhYWVdVbl9UTVVONjVTU1ZzbnU3QVp3OEhuYUpGdGpKY1Fwb2ZOTFNfNy1vWngtbzVPbndNZ0Y0LTRxUWNwUDNGaW55ZHhDenNMRmdVRXFKeXEtR2szMVhaRTluT0VoUFJiNkdtZlh6cmNzRmNZZVZVUUE?oc=5","date":"2019-06-06","type":"deal","source":"University of Central Florida","summary":"UCF Business Incubator Company Acquired in Nearly $70 Million Deal - University of Central Florida","headline":"UCF Business Incubator Company Acquired in Nearly $70 Million Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPQkxDbFUtMVFHMmt6OHFsdWhEc0NBV1hiQVpQTVhuUjVnbzYyOXVmeEUxcW5zZmxOQmxlS0pBUE03Q2xyRTZ5ek9VSlhjeUZmOXB2VVNoNDN4T1p4QzJibTdrdEtES3ZxMUJITHdObU1JT21tTUJlS3YtX2xoRnlrZS1ocVVXeVZHTFVSbVZFUW5KUXBNLVM2OU84c2Y?oc=5","date":"2019-02-06","type":"pipeline","source":"European Biotechnology Magazine","summary":"Kiadis Pharma appoints Dr. Robert Friesen as CSO - European Biotechnology Magazine","headline":"Kiadis Pharma appoints Dr. Robert Friesen as CSO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}